IFNA17 and systemic lupus erythematosus: The identification of SLE, CTD and pSS patients with an IFNα17/α2 ratio below 2x10-4 was intriguing, as results with recombinant molecules showed the extreme low probability of this phenotype occurring (Fig. 1e).